SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001571049-17-005185
Filing Date
2017-05-19
Accepted
2017-05-19 21:00:59
Documents
1
Period of Report
2017-05-17

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT t1701639_x1-bendheim.html 4  
1 OWNERSHIP DOCUMENT t1701639_x1-bendheim.xml 4 8004
  Complete submission text file 0001571049-17-005185.txt   9593
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Issuer) CIK: 0001069899 (see all company filings)

IRS No.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O EMPIRE RESOURCES, INC. 1 PARKER PLAZA, SUIET 10 FORT LEE NJ 07024
Business Address
BENDHEIM JACK (Reporting) CIK: 0001241560 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36410 | Film No.: 17859525